Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mikhail V. Ratushnyy
Clinical Cases of the Efficacy of Therapy Multikinase Inhibitors of Metastatic Radioid-Refractory Differentiated Thyroid Cancer
Endocrine Surgery
Related publications
Transferrin Receptor-Targeted HMSN for Sorafenib Delivery in Refractory Differentiated Thyroid Cancer Therapy
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Pcn5 - Treatments of Radioiodine-Refractory Differentiated Thyroid Cancer in Routine Clinical Practice – A Systematic Review
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Sorafenib for Treatment of Radioactive Iodine (Rai)-Refractory Locally Advanced/Metastatic Differentiated Thyroid Cancer (Dtc) in Turkey
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Exposure–response Analysis and Simulation of Lenvatinib Safety and Efficacy in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Prescribed Activity of 131 I Therapy in Differentiated Thyroid Cancer
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Differentiated Thyroid Cancer
Archives of Surgery
Clinical Evaluation of Recurrence After Initial Surgical Therapy for Differentiated Thyroid Carcinoma.
Practica Otologica
Otorhinolaryngology
Redifferentiation of Iodine-Refractory BRAF V600e-Mutant Metastatic Papillary Thyroid Cancer With Dabrafenib
Clinical Cancer Research
Cancer Research
Oncology
Impact of Adding the Multikinase Inhibitor Sorafenib to Endocrine Therapy in Metastatic Estrogen Receptor-Positive Breast Cancer
Future Oncology
Medicine
Cancer Research
Oncology
